BTG snaps up cryogenic oncology specialist Galil for £58.3M

London, UK, 06 May 2016

BTG Group is buying a US company that develops medical devices which kill tumours by freezing them, as it looks to further boost its presence in the world of interventional oncology.

Read More >

About Us